154 related articles for article (PubMed ID: 8770857)
41. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.
Suehiro T; Nakamura T; Inoue M; Shiinoki T; Ikeda Y; Kumon Y; Shindo M; Tanaka H; Hashimoto K
Atherosclerosis; 2000 Jun; 150(2):295-8. PubMed ID: 10856521
[TBL] [Abstract][Full Text] [Related]
42. Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?
Osei-Hyiaman D; Hou L; Mengbai F; Zhiyin R; Zhiming Z; Kano K
Eur J Endocrinol; 2001 Jun; 144(6):639-44. PubMed ID: 11375798
[TBL] [Abstract][Full Text] [Related]
43. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.
Suehiro T; Nakauchi Y; Yamamoto M; Arii K; Itoh H; Hamashige N; Hashimoto K
Int J Cardiol; 1996 Nov; 57(1):69-73. PubMed ID: 8960946
[TBL] [Abstract][Full Text] [Related]
44. Molecular variant of the human paraoxonase/arylesterase gene is associated with central retinal vein occlusion in the Japanese population.
Murata M; Nakagawa M; Takahashi S
Ophthalmologica; 1998; 212(4):257-9. PubMed ID: 9672215
[TBL] [Abstract][Full Text] [Related]
45. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
Schmidt H; Schmidt R; Niederkorn K; Gradert A; Schumacher M; Watzinger N; Hartung HP; Kostner GM
Stroke; 1998 Oct; 29(10):2043-8. PubMed ID: 9756579
[TBL] [Abstract][Full Text] [Related]
46. Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population.
Dessì M; Gnasso A; Motti C; Pujia A; Irace C; Casciani S; Staffa F; Federici G; Cortese C
Coron Artery Dis; 1999 Dec; 10(8):595-9. PubMed ID: 10599538
[TBL] [Abstract][Full Text] [Related]
47. Genetic polymorphism of paraoxonase and the risk of coronary heart disease.
Sanghera DK; Saha N; Aston CE; Kamboh MI
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1067-73. PubMed ID: 9194756
[TBL] [Abstract][Full Text] [Related]
48. Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.
Leviev I; Righetti A; James RW
J Mol Med (Berl); 2001 Aug; 79(8):457-63. PubMed ID: 11511976
[TBL] [Abstract][Full Text] [Related]
49. Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.
Ferré N; Tous M; Paul A; Zamora A; Vendrell JJ; Bardají A; Camps J; Richart C; Joven J
Clin Biochem; 2002 May; 35(3):197-203. PubMed ID: 12074827
[TBL] [Abstract][Full Text] [Related]
50. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects.
Heijmans BT; Westendorp RG; Lagaay AM; Knook DL; Kluft C; Slagboom PE
Atherosclerosis; 2000 Mar; 149(1):91-7. PubMed ID: 10704619
[TBL] [Abstract][Full Text] [Related]
51. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Chen Q; Reis SE; Kammerer CM; McNamara DM; Holubkov R; Sharaf BL; Sopko G; Pauly DF; Merz CN; Kamboh MI;
Am J Hum Genet; 2003 Jan; 72(1):13-22. PubMed ID: 12454802
[TBL] [Abstract][Full Text] [Related]
52. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
Adkins S; Gan KN; Mody M; La Du BN
Am J Hum Genet; 1993 Mar; 52(3):598-608. PubMed ID: 7916578
[TBL] [Abstract][Full Text] [Related]
53. Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.
Sen-Banerjee S; Siles X; Campos H
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2120-6. PubMed ID: 10978258
[TBL] [Abstract][Full Text] [Related]
54. Different pattern of association of paraoxonase Gln192-->Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease.
Scacchi R; Gambina G; Martini MC; Broggio E; Vilardo T; Corbo RM
Neurosci Lett; 2003 Mar; 339(1):17-20. PubMed ID: 12618290
[TBL] [Abstract][Full Text] [Related]
55. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases.
Imai Y; Morita H; Kurihara H; Sugiyama T; Kato N; Ebihara A; Hamada C; Kurihara Y; Shindo T; Oh-hashi Y; Yazaki Y
Atherosclerosis; 2000 Apr; 149(2):435-42. PubMed ID: 10729395
[TBL] [Abstract][Full Text] [Related]
56. The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese.
Sanghera DK; Saha N; Kamboh MI
Atherosclerosis; 1998 Feb; 136(2):217-23. PubMed ID: 9543091
[TBL] [Abstract][Full Text] [Related]
57. Paraoxonase and coronary heart disease risk: language misleads, linkage misinforms, function clarifies.
Loscalzo J
Circ Cardiovasc Genet; 2008 Dec; 1(2):79-80. PubMed ID: 20031548
[No Abstract] [Full Text] [Related]
58. High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients.
Leviev I; Poirier O; Nicaud V; Evans A; Kee F; Arveiler D; Morrisson C; Cambien F; James RW
Atherosclerosis; 2002 Apr; 161(2):463-7. PubMed ID: 11888532
[TBL] [Abstract][Full Text] [Related]
59. Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism.
Leviev I; Negro F; James RW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2935-9. PubMed ID: 9409279
[TBL] [Abstract][Full Text] [Related]
60. New data on the world distribution of paraoxonase (PON1 Gln 192 --> Arg) gene frequencies.
Scacchi R; Corbo RM; Rickards O; De Stefano GF
Hum Biol; 2003 Jun; 75(3):365-73. PubMed ID: 14527200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
